Study of the Relationship Between the Oxygenation State and Lung Ultrasound Score in Cardiac Surgery

NCT ID: NCT05470686

Last Updated: 2024-08-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-21

Study Completion Date

2025-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

After conventional cardiac surgery, many respiratory complications are possible. Therefore, the resuscitator prescribe physiotherapy and non invasive ventilation. The physiotherapist has few reliable tools to evaluate and follow the patient on his ventilatory function. Currently, lung ultrasound is little used in physiotherapy and no study explains the link between the lung ultrasound results and oxygenation patient state. Before considering the interest of lung ultrasound score as a criterion of effectiveness of a physiotherapy treatment through future studies, it is first important to objectivize the existence of a relationship between lung ultrasound score and the PaO2/FiO2 ratio after cardiac surgery. Lung ultrasound could provide direct clinical information without having to resort to other more invasive examinations to objectify the improvement of the patient's oxygenation.

Main objective To show that the relative change in the PaO2/FiO2 ratio correlates with the change in lung ultrasound score measured in the short term between the beginning and the end of the first physiotherapy session associated with non invasive ventilation the day after surgery in cardiac patients

Secondary objectives

* To study the inter-operator (2 readers) reproducibility of the lung ultrasound score measurement.
* To study the relationship between the relative variation of the PaO2/FiO2 ratio and the variation of each of the 12 zones of the lung ultrasound score
* To Study the relationship between the initial lung ultrasound score and the relative variation of the PaO2/FiO2 ratio
* To study the relative variation of the PaCO2 and the variation of the lung ultrasound score between the beginning and the end of the first session of physiotherapy management associated with NIV
* To obtain from the patient in the short term feedback on his or her understanding of the explanations about lung ultrasound score provided by the physiotherapist during the session

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HEART SURGERY PATIENTS with cardio pulmonary bypass

Group Type OTHER

blood gas via arterial catheter

Intervention Type BIOLOGICAL

Patients will have a blood sample plus a lung ultrasound before and after the physical therapy session combined with non invasive ventilation the morning after the heart surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

blood gas via arterial catheter

Patients will have a blood sample plus a lung ultrasound before and after the physical therapy session combined with non invasive ventilation the morning after the heart surgery

Intervention Type BIOLOGICAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Lung ultrasound score

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Person having received complete information on the organization of the research and having given written consent to participate
* Person having benefited from a heart surgery under cardio-pulmonary bypass
* Medical prescriptions for non invasive ventilation and physiotherapist
* Age ≥ 18 years
* 18.5 ≤ BMI ≤ 35 kg/m2
* Visual Analogy Scale pain \< 4
* Patient conscious and oriented: Glasgow 15/15

Exclusion Criteria

* At the patient's request : a patient may withdraw from the research at any time without affecting the quality of care to which he or she is entitled (withdrawal of consent).
* Cardiorespiratory arrest during the inclusion visit.
* Need for orotracheal reintubation during the inclusion visit.
* Patient non-cooperation during the inclusion visit.
* Failure of the ultrasound machine during the inclusion visit.
* Failure of the blood gas analyzer.
* Glasgow \< 15 during the inclusion visit
* PEEP \> 6 cmH2O required during physiotherapy + non invasive ventilation session
* PEEP \< 6 cmH2O required during physiotherapy + non invasive ventilation session
* Premature interruption of the physiotherapy session + non invasive ventilation not hemodynamically tolerated
* Need for a session of non invasive ventilation + physiotherapy \> 30 minutes.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Central Hospital, Nancy, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Aurelie OUDIN-ROTH

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jean PAYSANT

Role: STUDY_DIRECTOR

Central Hospital, Nancy, France

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

centralHNF

Vandœuvre-lès-Nancy, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Aurélie roth oudin

Role: CONTACT

03 83 15 41 96

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Aurelie ROTH OUDIN

Role: primary

03 83 15 41 96

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-A01478-35

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.